Outcomes of Reflex Cryptococcal Antigen (CrAg) Screening in Human Immunodeficiency Virus (HIV)-Positive Patients With CD4 Counts of 100-200 Cells/µL in Botswana.
Tenforde, MW; Milton, T; Rulaganyang, I; Muthoga, C; Tawe, L; Chiller, T; Greene, G; Jordan, A; Williams, CG; Owen, L; +5 more...Leeme, TB; Boose, A; Ngidi, J; Mine, M; Jarvis, JN
and
(2020)
Outcomes of Reflex Cryptococcal Antigen (CrAg) Screening in Human Immunodeficiency Virus (HIV)-Positive Patients With CD4 Counts of 100-200 Cells/µL in Botswana.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 72 (9).
pp. 1635-1638.
ISSN 1058-4838
DOI: 10.1093/cid/ciaa899
and
(2020)
Outcomes of Reflex Cryptococcal Antigen (CrAg) Screening in Human Immunodeficiency Virus (HIV)-Positive Patients With CD4 Counts of 100-200 Cells/µL in Botswana.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 72 (9).
pp. 1635-1638.
ISSN 1058-4838
DOI: 10.1093/cid/ciaa899
Increasing the CD4-count threshold for cryptococcal antigen (CrAg) screening from ≤100 to ≤200 cells/µL resulted in a 3-fold increase in numbers screened. CrAg-prevalence was 3.5% at CD4 101-200 and 6.2% ≤100 cells/µL. Six-month mortality was 21.4% (9/42) in CrAg-positive CD4 ≤100 cells/µL and 3.2% (1/31) in CrAg-positive CD4 101-200 cells/µL.
-
description - Manuscript[2].docx
-
subject - Accepted Version
-
- Available under Creative Commons: Attribution-NonCommercial-No Derivative Works 3.0
Downloads